Skip to main content

CAPITAL FUND MANAGEMENT S.A.

Position in AGIO — Agios Pharmaceuticals, Inc.

CIK 1323645 PARIS, I0

Position in AGIO

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$4,382,033
+$3,407,884 QoQ
Shares Held
129,531
+261.9% QoQ
Ownership
0.218%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
11 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in AGIO Over Time

Shares Held

Position Value (USD)

Derivatives in AGIO

reported options exposure · as of Mar 31, 2020
CallValue
$216,428
CallShares
6,100
PutValue
$259,004
PutShares
7,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

CAPITAL FUND MANAGEMENT S.A. holds $292,594,996 across 34 Biotechnology names. AGIO ranks #15 (1.5% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in AGIO

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $4,382,033 129,531
2025-12-31 $974,149 35,788
2025-06-30 $2,278,376 68,502
2025-03-31 $2,118,448 72,302
2023-06-30 $1,174,005 41,455
2023-03-31 $705,615 30,719
2022-12-31 $1,469,033 52,316
2022-09-30 $375,388 13,274
2020-09-30 $1,198,190 34,234
2020-06-30 $745,564 13,941
2020-03-31 $259,004 7,300
2020-03-31 $216,428 6,100